nodes	percent_of_prediction	percent_of_DWPC	metapath
Olsalazine—IFNG—epithelium—vaginal cancer	0.0466	0.0823	CbGeAlD
Olsalazine—IFNG—uterus—vaginal cancer	0.0385	0.068	CbGeAlD
Olsalazine—IFNG—Interferon Signaling—EIF4A3—vaginal cancer	0.0362	0.0836	CbGpPWpGaD
Olsalazine—IFNG—female reproductive system—vaginal cancer	0.0346	0.0611	CbGeAlD
Olsalazine—IFNG—vagina—vaginal cancer	0.0313	0.0553	CbGeAlD
Olsalazine—IFNG—Downstream signaling in naïve CD8+ T cells—IFNA1—vaginal cancer	0.0288	0.0663	CbGpPWpGaD
Olsalazine—TPMT—uterine cervix—vaginal cancer	0.0266	0.047	CbGeAlD
Olsalazine—IFNG—IL27-mediated signaling events—IL2—vaginal cancer	0.0251	0.0578	CbGpPWpGaD
Olsalazine—TPMT—urethra—vaginal cancer	0.0245	0.0432	CbGeAlD
Olsalazine—IFNG—Cytokines and Inflammatory Response—IL2—vaginal cancer	0.0243	0.0561	CbGpPWpGaD
Olsalazine—IFNG—Cytokine Signaling in Immune system—EIF4A3—vaginal cancer	0.0242	0.0558	CbGpPWpGaD
Olsalazine—TPMT—endometrium—vaginal cancer	0.0241	0.0425	CbGeAlD
Olsalazine—TPMT—mammalian vulva—vaginal cancer	0.0233	0.0411	CbGeAlD
Olsalazine—IFNG—Calcium signaling in the CD4+ TCR pathway—IL2—vaginal cancer	0.023	0.053	CbGpPWpGaD
Olsalazine—IFNG—Inflammatory Response Pathway—IL2—vaginal cancer	0.0223	0.0515	CbGpPWpGaD
Olsalazine—IFNG—IL12 signaling mediated by STAT4—IL2—vaginal cancer	0.0223	0.0515	CbGpPWpGaD
Olsalazine—ALOX5—urethra—vaginal cancer	0.0216	0.0381	CbGeAlD
Olsalazine—IFNG—IL23-mediated signaling events—IL2—vaginal cancer	0.0189	0.0436	CbGpPWpGaD
Olsalazine—TPMT—female gonad—vaginal cancer	0.0182	0.032	CbGeAlD
Olsalazine—TPMT—vagina—vaginal cancer	0.018	0.0318	CbGeAlD
Olsalazine—PPARG—epithelium—vaginal cancer	0.0178	0.0314	CbGeAlD
Olsalazine—ALOX5—female reproductive system—vaginal cancer	0.0176	0.031	CbGeAlD
Olsalazine—PPARG—urethra—vaginal cancer	0.0162	0.0286	CbGeAlD
Olsalazine—ALOX5—female gonad—vaginal cancer	0.016	0.0282	CbGeAlD
Olsalazine—IFNG—Aryl Hydrocarbon Receptor Pathway—IL2—vaginal cancer	0.0159	0.0366	CbGpPWpGaD
Olsalazine—PPARG—mammalian vulva—vaginal cancer	0.0154	0.0272	CbGeAlD
Olsalazine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—vaginal cancer	0.0148	0.0343	CbGpPWpGaD
Olsalazine—PPARG—uterus—vaginal cancer	0.0147	0.0259	CbGeAlD
Olsalazine—IFNG—IL2-mediated signaling events—IL2—vaginal cancer	0.014	0.0322	CbGpPWpGaD
Olsalazine—IFNG—Interferon Signaling—IFNA1—vaginal cancer	0.0136	0.0313	CbGpPWpGaD
Olsalazine—PPARG—female reproductive system—vaginal cancer	0.0132	0.0233	CbGeAlD
Olsalazine—IFNG—SHP2 signaling—IL2—vaginal cancer	0.0132	0.0304	CbGpPWpGaD
Olsalazine—IFNG—IL12-mediated signaling events—IL2—vaginal cancer	0.0128	0.0296	CbGpPWpGaD
Olsalazine—PPARG—female gonad—vaginal cancer	0.012	0.0212	CbGeAlD
Olsalazine—PPARG—vagina—vaginal cancer	0.0119	0.0211	CbGeAlD
Olsalazine—IFNG—Downstream signaling in naïve CD8+ T cells—IL2—vaginal cancer	0.0119	0.0274	CbGpPWpGaD
Olsalazine—IFNG—Folate Metabolism—IL2—vaginal cancer	0.0119	0.0274	CbGpPWpGaD
Olsalazine—IFNG—Regulation of Telomerase—IL2—vaginal cancer	0.0116	0.0268	CbGpPWpGaD
Olsalazine—IFNG—AP-1 transcription factor network—IL2—vaginal cancer	0.0113	0.0262	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—IL2—vaginal cancer	0.0103	0.0238	CbGpPWpGaD
Olsalazine—IFNG—Glucocorticoid receptor regulatory network—IL2—vaginal cancer	0.00999	0.0231	CbGpPWpGaD
Olsalazine—PTGS1—epithelium—vaginal cancer	0.0095	0.0168	CbGeAlD
Olsalazine—PTGS1—uterine cervix—vaginal cancer	0.00942	0.0166	CbGeAlD
Olsalazine—PTGS2—epithelium—vaginal cancer	0.00908	0.016	CbGeAlD
Olsalazine—IFNG—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.00905	0.0209	CbGpPWpGaD
Olsalazine—PTGS2—uterine cervix—vaginal cancer	0.00901	0.0159	CbGeAlD
Olsalazine—PTGS1—endometrium—vaginal cancer	0.00852	0.015	CbGeAlD
Olsalazine—PTGS2—urethra—vaginal cancer	0.00828	0.0146	CbGeAlD
Olsalazine—PTGS1—mammalian vulva—vaginal cancer	0.00824	0.0145	CbGeAlD
Olsalazine—PTGS2—endometrium—vaginal cancer	0.00814	0.0144	CbGeAlD
Olsalazine—IFNG—Immune System—EIF4A3—vaginal cancer	0.0079	0.0182	CbGpPWpGaD
Olsalazine—PTGS1—uterus—vaginal cancer	0.00785	0.0139	CbGeAlD
Olsalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—vaginal cancer	0.00766	0.0177	CbGpPWpGaD
Olsalazine—PTGS2—uterus—vaginal cancer	0.00751	0.0132	CbGeAlD
Olsalazine—IFNG—Spinal Cord Injury—IL2—vaginal cancer	0.00747	0.0172	CbGpPWpGaD
Olsalazine—PTGS1—female reproductive system—vaginal cancer	0.00706	0.0125	CbGeAlD
Olsalazine—PTGS2—female reproductive system—vaginal cancer	0.00675	0.0119	CbGeAlD
Olsalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—vaginal cancer	0.00659	0.0152	CbGpPWpGaD
Olsalazine—PTGS1—female gonad—vaginal cancer	0.00642	0.0113	CbGeAlD
Olsalazine—PTGS1—vagina—vaginal cancer	0.00638	0.0113	CbGeAlD
Olsalazine—PTGS2—female gonad—vaginal cancer	0.00614	0.0108	CbGeAlD
Olsalazine—PTGS2—vagina—vaginal cancer	0.0061	0.0108	CbGeAlD
Olsalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—vaginal cancer	0.00426	0.00983	CbGpPWpGaD
Olsalazine—PPARG—Gene Expression—EIF4A3—vaginal cancer	0.00406	0.00936	CbGpPWpGaD
Olsalazine—IFNG—Cytokine Signaling in Immune system—IL2—vaginal cancer	0.00374	0.00863	CbGpPWpGaD
Olsalazine—IFNG—Immune System—IFNA1—vaginal cancer	0.00296	0.00682	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—IL2—vaginal cancer	0.00214	0.00495	CbGpPWpGaD
Olsalazine—IFNG—Immune System—IL2—vaginal cancer	0.00122	0.00282	CbGpPWpGaD
